CLC Number:
ZHANG Qing-li, ZHANG Yun, WU Ai-rong, et al. EFFECTS OF ERLOTINIB ON CURATIVE EFFECTS AND SURVIVAL RATE OF NSCLC PATIENTS WITH DIFFERENT MUTANTS OF EGFR GENE[J]. Journal of Chengde Medical University, 2019, 36(3): 202-204.
张庆丽, 张筠, 伍爱荣, 刘德勇. 厄洛替尼对EGFR基因不同突变型NSCLC患者疗效及生存率的影响*[J]. 承德医学院学报, 2019, 36(3): 202-204.